Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury
Ischemia-reperfusion (I/R) is a pathological process that occurs in many organs and diseases. Reperfusion, recovery of blood flow, and reoxygenation often lead to reperfusion injury. Drug therapy and early reperfusion therapy can reduce tissue injury and cell necrosis caused by ischemia, leading to...
Guardado en:
Autores principales: | Xinye Li, Ning Ma, Juping Xu, Yanchi Zhang, Pan Yang, Xin Su, Yanfeng Xing, Na An, Fan Yang, Guoxia Zhang, Lijing Zhang, Yanwei Xing |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f913e1ed6d1e4623b47ba4e986f43a48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy
por: Yani Wang, et al.
Publicado: (2021) -
Ubiquitin-Specific Protease 29 Exacerbates Cerebral Ischemia-Reperfusion Injury in Mice
por: Jia-Bao Hou, et al.
Publicado: (2021) -
Emerging Pathological Engagement of Ferroptosis in Gut Diseases
por: Weihua Gao, et al.
Publicado: (2021) -
Mitochondrial Transplantation Attenuates Cerebral Ischemia-Reperfusion Injury: Possible Involvement of Mitochondrial Component Separation
por: Qiang Xie, et al.
Publicado: (2021) -
Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis
por: Dingyi Lv, et al.
Publicado: (2021)